Individuals with 45,X mosaicism with Y chromosome material raised as boys are not diagnosed with Turner syndrome, a label restricted to phenotypic females. We sought to determine if boys with 45,X mosaicism had features consistent with Turner syndrome. Twenty-two patients (14 girls, 8 boys) seen in our Differences of Sex Development (DSD) clinic were identified for review. Standardized height (z-scores) by sex of rearing and results of cardiology, renal, audiology, thyroid, and celiac screenings were recorded. All subjects had heights below the mean for sex. Z-scores were not significantly different between boys and girls (p = 0.185). There were no significant differences in the incidence of cardiac anomalies between boys and girls (p = 0.08). Girls were more likely to have additional screenings (p = 0.042), but there were no significant differences in the number of positive screenings between boys and girls (p = 0.332). Patients with 45,X mosaicism raised as boys appear to have features similar to patients with the same karyotype raised as girls. Routine screening of boys following the Turner Syndrome Clinical Practice Guidelines may allow early recognition of comorbidities. Additionally, obtaining karyotypes on boys with short stature or other features of Turner syndrome may identify unrecognized cases of 45,X mosaicism.

1.
Ahmed
SF
,
Khwaja
O
,
Hughes
IA
.
The role of a clinical score in the assessment of ambiguous genitalia
.
BJU Int
.
2000
;
85
:
120
4
. .
2.
Bertelloni
S
,
Baroncelli
GI
,
Massart
F
,
Toschi
B
.
Growth in boys with 45,X/46,XY mosaicism: Effect of growth hormone treatment on statural growth
.
Sex Dev
.
2015
;
9
:
183
9
. .
3.
Centers for Disease Control
.
Growth Charts - Z-score Data Files
.
2019
. [cited 2020, Nov 10]. Available from:https://www.cdc.gov/growthcharts/zscore.
4.
Chang
HJ
,
Clark
RD
,
Bachman
H
.
The phenotype of 45,X/46,XY mosaicism: an analysis of 92 prenatally diagnosed cases
.
Am J Hum Genet
.
1990
;
46
:
156
67
.
5.
Colindres
JV
,
Axelrad
M
,
McCullough
L
,
Smith
EO
,
Huang
GO
,
Tu
DD
,
Evidence-based management of patients with 45,X/46,XY gonadal dysgenesis and male sex assignment: from infancy to adulthood
.
Pediatr Endocrinol Rev
.
2016
;
13
:
585
601
.
6.
Cools
M
,
Pleskacova
J
,
Stoop
H
,
Hoebeke
P
,
Van Laecke
E
,
Drop
SL
,
Gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45,X/46,XY mosaicism
.
J Clin Endocrinol Metab
.
2011
;
96
:
E1171
80
. .
7.
De Groote
K
,
Cools
M
,
De Schepper
J
,
Craen
M
,
François
I
,
Devos
D
,
Cardiovascular pathology in males and females with 45,X/46,XY mosaicism
.
PloS One
.
2013
;
8
:
e54977
. .
8.
Dumeige
L
,
Chatelais
L
,
Bouvattier
C
,
De Kerdanet
M
,
Hyon
C
,
Esteva
B
,
Should 45,X/46,XY boys with no or mild anomaly of external genitalia be investigated and followed up
?
Eur J Endocrinol
.
2018
;
179
:
181
90
. .
9.
Efthymiadou
A
,
Stefanou
EG,
,
Chrysis
D
.
45,X/46,XY mosaicism: a cause of short stature in males
.
Hormones (Athens)
.
2012
;
11
:
501
4
.
10.
Ford
CE
,
Jones
KW
,
Polani
PE
,
De Almeida
JC
,
Briggs
JH
.
A sex-chromosome anomaly in a case of gonadal dysgenesis (Turner’s syndrome)
.
Lancet
.
1959
;
1
:
711
3
.
11.
Gravholt
CH
,
Andersen
NH
,
Conway
GS
,
Dekkers
OM
,
Geffner
ME
,
Klein
KO
,
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
.
Eur J Endocrinol
.
2017
;
177
:
G1
G70
. .
12.
Griffiths
DA
.
Shifting syndromes: Sex chromosome variations and intersex classifications
.
Soc Stud Sci
.
2018
;
48
:
125
48
. .
13.
Guedes
AD
,
Bianco
B
,
Lipay
MV
,
Brunoni
D
,
de Lourdes Chauffaille
M
,
Verreschi
IT
.
Determination of the sexual phenotype in a child with 45,X/46,X,Idic(Yp) mosaicism: importance of the relative proportion of the 45,X line in gonadal tissue
.
Am J Med Genet A
.
2006
;
140A
:
1871
5
. .
14.
Guzewicz
L
,
Howell
S
,
Crerand
CE
,
Umbaugh
H
,
Nokoff
NJ
,
Barker
J
,
Clinical phenotype and management of individuals with mosaic monosomy X with Y chromosome material stratified by genital phenotype
.
Am J Med Genet A
.
2021
;
185
(
5
):
1437
47
. .
15.
Hojat
L
,
Schweiger
M
.
45,X/46,XY mosaicism and possible association with hypothyroidism in males
.
Clin Pediatr (Phila)
.
2016
;
55
(
6
):
549
51
. .
16.
Layman
LC
,
Tho
SP
,
Clark
AD
,
Kulharya
A
,
McDonough
PG
.
Phenotypic spectrum of 45,X/46,XY males with a ring Y chromosome and bilaterally descended testes
.
Fertil Steril
.
2009
;
91
:
791
7
. .
17.
Lindhardt Johansen
M
,
Hagen
CP
,
Rajpert-De Meyts
E
,
Kjærgaard
S
,
Petersen
BL
,
Skakkebæk
NE
,
45,X/46,XY mosaicism: phenotypic characteristics, growth, and reproductive function—a retrospective longitudinal study
.
J Clin Endocrinol Metab
.
2012
;
97
:
E1540
E1549
.
18.
Ljubicic
ML
,
Jørgensen
A
,
Acerini
C
,
Andrade
J
,
Balsamo
A
,
Bertelloni
S
,
Clinical but not histological outcomes in males with 45,X/46,XY mosaicism vary depending on reason for diagnosis
.
J Clin Endocrinol Metab
.
2019
;
104
:
4366
81
. .
19.
Martinerie
L
,
Morel
Y
,
Gay
CL
,
Pienkowski
C
,
de Kerdanet
M
,
Cabrol
S
,
Impaired puberty, fertility, and final stature in 45,X/46,XY mixed gonadal dysgenetic patients raised as boys
.
Eur J Endocrinol
.
2012
;
166
:
687
94
. .
20.
Matsumoto
F
,
Matsuyama
S
,
Matsui
F
,
Yazawa
K
,
Matsuoka
K
.
Variation of Gonadal Dysgenesis and Tumor Risk in Patients With 45,X/46,XY Mosaicism
.
Urology
.
2020
;
137
:
157
60
. .
21.
Richter-Unruh
A
,
Knauer-Fischer
S
,
Kaspers
S
,
Albrecht
B
,
Gillessen-Kaesbach
G
,
Hauffa
BP
.
Short stature in children with an apparently normal male phenotype can be caused by 45,X/46,XY mosaicism and is susceptible to growth hormone treatment
.
Eur J Pediatr
.
2004
;
163
:
251
6
. .
22.
Shinawi
M
,
Cain
MP
,
Vanderbrink
BA
,
Grignon
DJ
,
Mensing
D
,
Cooper
ML
,
Mixed gonadal dysgenesis in a child with isodicentric Y chromosome: Does the relative proportion of the 45,X line really matter
?
Am J Med Genet A
.
2010
;
152A
:
1832
7
. .
23.
Silvestre
C
,
Dupont
J
,
Silveira Santos
R
,
Robalo
B
,
Pereira
C
,
Sampaio
ML
.
Short stature on a boy: mosaicism with an isodicentric Y chromosome
.
Case Rep Pediatr
.
2019
;
2019
:
8563095
6
. .
24.
Telvi
L
,
Lebbar
A
,
Del Pino
O
,
Barbet
JP
,
Chaussain
JL
.
45,X/46,XY mosaicism: Report of 27 cases
.
Pediatrics
.
1999
;
104
:
304
8
. .
25.
Tosson
H
,
Rose
SR
,
Gartner
LA
.
Children with 45,X/46,XY karyotype from birth to adult height
.
Horm Res Paediatr
.
2010
;
74
:
190
200
. .
26.
Tosson
H
,
Rose
SR
,
Gartner
LA
.
Description of children with 45,X/46,XY karyotype
.
Eur J Pediatr
.
2012
;
171
:
521
9
. .
27.
Turner
HH
.
A syndrome of infantilism, congenital webbed neck and cubitus valgus
.
Endocrinology
.
1938
;
23
:
566
74
.
28.
van der Linde
D
,
Konings
EE
,
Slager
MA
,
Witsenburg
M
,
Helbing
WA
,
Takkenberg
JJ
,
Birth prevalence of congenital heart disease worldwide: A systematic review and meta-analysis
.
J Am Coll Cardiol
.
2011
;
58
:
2241
7
. .
29.
Wiedemann
HR
,
Glatzl
J
.
Follow-up of Ullrich's original patient with "Ullrich-Turner" syndrome
.
Am J Med Genet
.
1991
;
41
:
134
6
. .
30.
Wu
Q
,
Wang
C
,
Shi
H
,
Kong
X
,
Ren
S
,
Jiang
M
.
The clinical manifestation and genetic evaluation in patients with 45,X/46,XY mosaicism
.
Sex Dev
.
2017
;
11
:
64
9
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.